Analysis of HCV Genotype 2 and 3 Variants in Patients Treated with Combination Therapy of Next Generation HCV Direct-Acting Antiviral Agents ABT-493 and ABT-530

2016 ◽  
Vol 64 (2) ◽  
pp. S409-S410 ◽  
Author(s):  
T. Ng ◽  
T. Pilot-Matias ◽  
R. Tripathi ◽  
G. Schnell ◽  
T. Reisch ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Antiviral Agents ◽  
Next Generation ◽  
Hcv Genotype ◽  
Direct Acting Antiviral ◽  
Genotype 2 ◽  
Hcv Genotype 2 ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents

scholarly journals Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents

Viruses ◽  
2017 ◽  
Vol 9 (8) ◽  
pp. 212 ◽  
Author(s):  
Barbara Bartolini ◽  
Emanuela Giombini ◽  
Chiara Taibi ◽  
Raffaella Lionetti ◽  
Marzia Montalbano ◽  
...  
Keyword(s):  
Antiviral Agents ◽  
Hcv Genotype ◽  
Direct Acting Antiviral ◽  
Naturally Occurring ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents ◽  
Genotype 3A
Sign in / Sign up

Export Citation Format

Share Document